<DOC>
	<DOCNO>NCT00401479</DOCNO>
	<brief_summary>This study test hypothesis GW427353 , beta-3 adrenergic agonist , retard empty colon increase total colonic transit time .</brief_summary>
	<brief_title>A Study To Investigate The Effect Of Solabegron ( GW427353 ) On Gastrointestinal Transit In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Solabegron</mesh_term>
	<mesh_term>Adrenergic Agonists</mesh_term>
	<criteria>Subjects evidence current past history suggestive gastrointestinal disease disorder medical illness could compromise interpretation study . clinically significant laboratory result collect screen visit men : body weight great equal 50kg ( 110 lb ) woman : body weight great equal 45kg ( 100 lb ) BMI 18.5 35 kg/m2 Females nursing pregnant . history inflammatory bowel disease history gastric ulcer within 12 month sign informed consent form tobacco user</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>GW427353</keyword>
	<keyword>b3-Adrenergic Receptor Agonist</keyword>
	<keyword>Irritable Bowel Syndrome ( IBS )</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>tolerability</keyword>
	<keyword>gastrointestinal transit</keyword>
</DOC>